Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Year Later, Indian Import Duties Still In Place On Cancer Drugs

This article was originally published in PharmAsia News

Executive Summary

Import duties still in place in India on the most promising cancer drugs are keeping the price to Indians at about 35 percent more than prices charged elsewhere in the world. The import duties were to have been lifted early last year on certain life-saving drugs, but red tape apparently has delayed the exemptions. A Finance Ministry official said the agency still had not received a recommendation from the Health Ministry for drugs to be placed on a list of exempted drugs. The government had listed 14 cancer drugs that were supposed to be exempt from countervailing duties and have import duties reduced to 5 percent. (Click here for more



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts